Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
- Eui Soon Kim
- , Sun Kyeong Park
- , Jong Chan Youn
- , Hye Sun Lee
- , Hae Young Lee
- , Hyun Jai Cho
- , Jin Oh Choi
- , Eun Seok Jeon
- , Sang Eun Lee
- , Min Seok Kim
- , Jae Joong Kim
- , Kyung Kuk Hwang
- , Myeong Chan Cho
- , Shung Chul Chae
- , Seok Min Kang
- , Jin Joo Park
- , Dong Ju Choi
- , Byung Su Yoo
- , Jae Yeong Cho
- , Kye Hun Kim
- Korea Advanced Institute of Science and Technology
- The Catholic University of Korea
- Yonsei University
- Seoul National University
- Sungkyunkwan University
- University of Ulsan
- Chungbuk National University
- Kyungpook National University
- Yonsei University Wonju College of Medicine
- Chonnam National University
- Incheon Sejong Hospital
- University of California at San Diego
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Scopus
citations